SINAPIS PHARMA, INC. — Form D/A
SINAPIS PHARMA, INC. of JACKSONVILLE, FL, a company, filed a Form D amendment with the SEC on 2010-05-19. The offering totals $750K, of which $511K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-05-19
- Form: D/A
- Accession: 0001492347-10-000003
- Industry: Biotechnology
- Exemptions: 06, 46
- Total offering: $750K
- Amount sold: $511K
- Remaining: $239K
- Investors: 17
- Date of first sale: 2009-09-30
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-142294
Issuer
- Name: SINAPIS PHARMA, INC.
- CIK: 0001492347
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 4350 PABLO PROFESSIONAL COURT, STE. 200, JACKSONVILLE, FL, 32224
- Phone: 904-619-0043
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| DONALD C PICKER | Director | LIVINGSTON, NJ |
| DONALD C PICKER | Executive Officer | LIVINGSTON, NJ |
| ALBERT C HENRY | Director | JACKSONVILLE, FL |
| JAMES C FONGER | Executive Officer | ATLANTA, GA |
| HOWARD C CHANDLER, JR. | Director | ATLANTA, GA |
| HOWARD C CHANDLER, JR. | Executive Officer | ATLANTA, GA |
Other filings by this issuer (4)
More